Streetbeat News

Products Services

BMY

Bristol Myers Squibb presented data from the Phase 3 CheckMate -9DW trial, showing that the combination of Opdivo and Yervoy improved overall survival in patients with advanced hepatocellular carcinoma compared to Lenvatinib or Sorafenib.

Portfolio Pulse from Benzinga Newsdesk

June 04, 2024 | 12:14 pm

NTAP

NetApp (NASDAQ:NTAP) has expanded its relationship with Porsche Motorsport to become the exclusive Intelligent Data Infrastructure partner, enhancing data access for strategic decision-making in various racing championships.

Portfolio Pulse from Benzinga Newsdesk

June 04, 2024 | 12:13 pm

BIVI

BioVie has formed an advisory board to provide strategic guidance for its drug Bezisterim, which is being developed to treat Long COVID.

Portfolio Pulse from Benzinga Newsdesk

June 04, 2024 | 12:13 pm

AAPL

NVDA

Nvidia's market cap is nearing $3 trillion, driven by its leadership in AI technology, while Apple remains slightly ahead. Gene Munster of Deepwater Asset Management suggests Apple could generate better returns over the next year due to its AI potential, despite a possible short-term dip following the Worldwide Developer Conference keynote.

Portfolio Pulse from Shanthi Rexaline

June 04, 2024 | 12:13 pm

SOBR

SOBR Safe shares are trading higher following the announcement that two new customers have purchased the SOBRsure device.

Portfolio Pulse from Benzinga Newsdesk

June 04, 2024 | 12:10 pm

CUE

Cue Biopharma presented updated data from its Phase 1 trial of CUE-101 in recurrent/metastatic HPV+ head and neck cancer at ASCO 2024. The trial showed a 46% overall response rate and a 12-month overall survival rate of 96% in first-line treatment with CUE-101 and KEYTRUDA. Median overall survival in second-line treatment with CUE-101 monotherapy was 20.8 months, significantly higher than historical data.

Portfolio Pulse from Benzinga Newsdesk

June 04, 2024 | 12:10 pm

GH

Guardant Health has launched an upgraded version of its Guardant360 TissueNext test, which now includes 498 biomarkers to help identify more treatment options for patients with advanced cancer. The test is covered by Medicare and features operational improvements for faster results.

Portfolio Pulse from Benzinga Newsdesk

June 04, 2024 | 12:09 pm

SOBR

SOBR Safe has signed hardware and software agreements with Hired Power and The Firm, both of which have made initial purchases of SOBRsure devices.

Portfolio Pulse from Benzinga Newsdesk

June 04, 2024 | 12:09 pm

BNZI

Banzai has announced the addition of support for AI-powered phone agents, enhancing its customer service capabilities. This move is expected to improve efficiency and customer satisfaction.

Portfolio Pulse from Benzinga Newsdesk

June 04, 2024 | 12:07 pm

PINS

VTEX

Pinterest and VTEX have announced a partnership to expand social commerce, allowing consumer brands to reach Pinterest's high-intent audience and make their products available for purchase.

Portfolio Pulse from Benzinga Newsdesk

June 04, 2024 | 12:07 pm